Market Research Logo

Liver Transplant Rejection - Pipeline Review, H2 2018

Liver Transplant Rejection - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection - Pipeline Review, H2 2018, provides an overview of th


Introduction
Global Markets Direct Report Coverage
Liver Transplant Rejection - Overview
Liver Transplant Rejection - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Liver Transplant Rejection - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Liver Transplant Rejection - Companies Involved in Therapeutics Development
Alexion Pharmaceuticals Inc
Dompe Farmaceutici SpA
Novartis AG
RedHill Biopharma Ltd
Veloxis Pharmaceuticals A/S
Liver Transplant Rejection - Drug Profiles
ABC-294640 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cellular Immunotherapy for Liver Transplant Rejection - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cellular Immunotherapy for Liver Transplantation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cellular Immunotherapy for Liver Transplantation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
eculizumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
emricasan - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FX-06 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy for High-Grade Glioma and Liver Transplantation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
iscalimab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDR-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDR-202 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDR-203 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDR-204 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
reparixin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tacrolimus ER - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TR-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tregcel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Triplex - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Liver Transplant Rejection - Dormant Projects
Liver Transplant Rejection - Discontinued Products
Liver Transplant Rejection - Product Development Milestones
Featured News & Press Releases
Nov 16, 2015: Conatus Pharmaceuticals Announces Poster Presentations at AASLD Annual Meeting
May 12, 2014: Conatus Pharmaceuticals Initiates Phase 2b Trial Targeting Fibrosis in Liver Transplant Recipients
Nov 02, 2013: Conatus Pharmaceuticals Presents Data Demonstrating Emricasan's Safety Profile at the AASLD Liver Meeting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Liver Transplant Rejection, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Liver Transplant Rejection - Pipeline by Alexion Pharmaceuticals Inc, H2 2018
Liver Transplant Rejection - Pipeline by Dompe Farmaceutici SpA, H2 2018
Liver Transplant Rejection - Pipeline by Novartis AG, H2 2018
Liver Transplant Rejection - Pipeline by RedHill Biopharma Ltd, H2 2018
Liver Transplant Rejection - Pipeline by Veloxis Pharmaceuticals A/S, H2 2018
Liver Transplant Rejection - Dormant Projects, H2 2018
Liver Transplant Rejection - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for Liver Transplant Rejection, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report